Preparation and characterization of self-assembled nanoparticles based on low-molecular-weight heparin and stearylamine conjugates for controlled delivery of docetaxel

References

• KwonGSOkanoTPolymeric micelles as new drug carriersAdv Drug Deliv Rev1996212107116
   Web of Science ®Google Scholar
• LiuZJiaoYWangYPolysaccharides-based nanoparticles as drug delivery systemsAdv Drug Deliv Rev200860151650166218848591
   PubMed Web of Science ®Google Scholar
• MaedaHWuJSawaTTumor vascular permeability and the EPR effect in macromolecular therapeutics: a reviewJ Control Release200065127128410699287
   PubMed Web of Science ®Google Scholar
• MaedaHTumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospectsBioconjugate Chem2010215797802
   PubMed Web of Science ®Google Scholar
• VerrecchiaTSpenlehauerGBazileDNon-stealth (poly(lactic acid/albumin)) and stealth (poly(lactic acid-polyethylene glycol)) nanoparticles as injectable drug carriersJ Control Release19953614961
   Web of Science ®Google Scholar
• ShaoXLiuQZhangCConcanavalin A-conjugated poly(ethylene glycol)-poly(lactic acid) nanoparticles for intranasal drug delivery to the cervical lymph nodesJ Microencapsul201330878078623631383
   PubMed Web of Science ®Google Scholar
• LabhasetwarVSongCHumphreyWArterial uptake of biodegradable nanoparticles: effect of surface modificationsJ Pharm Sci19988710122912349758682
   PubMed Web of Science ®Google Scholar
• MolpeceresJGuzmanMAberturasMRApplication of central composite designs to the preparation of polycaprolactone nanoparticles by solvent displacementJ Pharm Sci19968522062138683450
   PubMed Web of Science ®Google Scholar
• AishwaryaSMahalakshmiSSehgalPKCollagen-coated polycaprolactone microparticles as a controlled drug delivery systemJ Microencapsul200825529830618465301
   PubMed Web of Science ®Google Scholar
• SharmaSBensonHAMukkurTKPreliminary studies on the development of IgA-loaded chitosan-dextran sulphate nanoparticles as a potential nasal delivery system for protein antigensJ Microencapsul201330328329422994538
   PubMed Web of Science ®Google Scholar
• JahanshahiMBabaeiZProtein nanoparticle: a unique system as drug delivery vehiclesAfr J Biotechnol200872549264934
   Web of Science ®Google Scholar
• WuYMacKayJAMcDanielJRFabrication of elastin-like polypeptide nanoparticles for drug delivery by electrosprayingBiomacromolecules2008101192419072041
   PubMed Web of Science ®Google Scholar
• KwonGSOkanoTSoluble self-assembled block copolymers for drug deliveryPharm Res199916559760010349998
   PubMed Web of Science ®Google Scholar
• SaravanakumarGMinKHMinDSHydrotropic oligomer-conjugated glycol chitosan as a carrier of paclitaxel: synthesis, characterization, and in vivo biodistributionJ Control Release2009140321021719560497
   PubMed Web of Science ®Google Scholar
• SunPZhangYShiLThermosensitive nanoparticles self-assembled from PCL-b-PEO-b-PNIPAAm triblock copolymers and their potential for controlled drug releaseMacromol Biosci201010662163120166233
   PubMed Web of Science ®Google Scholar
• Lyseng-WilliamsonKAFentonCDocetaxelDrugs200565172513253116296875
   PubMed Web of Science ®Google Scholar
• BakerSDSparreboomAVerweijJClinical pharmacokinetics of docetaxelClin Pharmacokinet200645323525216509758
   PubMed Web of Science ®Google Scholar
• MichaelASyrigosKPandhaHProstate cancer chemotherapy in the era of targeted therapyProstate Cancer Prostatic Dis2008121131618521103
   PubMed Web of Science ®Google Scholar
• PersohnECantaASchoepferSMorphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in ratsEur J Cancer200541101460146615913989
   PubMed Web of Science ®Google Scholar
• EngelsFKMathotRAVerweijJAlternative drug formulations of docetaxel: a reviewAnticancer Drugs20071829510317159596
   PubMed Web of Science ®Google Scholar
• ImmordinoMLBrusaPArpiccoSPreparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxelJ Control Release200391341742912932719
   PubMed Web of Science ®Google Scholar
• YinY-MCuiF-DMuC-FDocetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluationJ Control Release20091402869419709639
   PubMed Web of Science ®Google Scholar
• EsmaeiliFDinarvandRGhahremaniMHDocetaxel–albumin conjugates: preparation, in vitro evaluation and biodistribution studiesJ Pharm Sci20099882718273018972321
   PubMed Web of Science ®Google Scholar
• BullerHGentMGallusALow-molecular weight heparin in the treatment of patients with venous thromboembolism: the Columbus InvestigatorsN Engl J Med19973376576629280815
   PubMed Web of Science ®Google Scholar
• YoungEThe anti-inflammatory effects of heparin and related compoundsThromb Res2008122674375217727922
   PubMed Web of Science ®Google Scholar
• NiersTMHKlerkCPWDiNisioMMechanisms of heparin induced anti-cancer activity in experimental cancer modelsCrit Rev Oncol Hematol200761319520717074500
   PubMed Web of Science ®Google Scholar
• CastelliRPorroFTarsiaPThe heparins and cancer: review of clinical trials and biological propertiesVasc Med20049320521315675186
   PubMed Web of Science ®Google Scholar
• MarchettiMVignoliARussoLEndothelial capillary tube formation and cell proliferation induced by tumor cells are affected by low molecular weight heparins and unfractionated heparinThromb Res2008121563764517692905
   PubMed Web of Science ®Google Scholar
• BaeKHMokHParkTGSynthesis, characterization, and intracellular delivery of reducible heparin nanogels for apoptotic cell deathBiomaterials200829233376338318474396
   PubMed Web of Science ®Google Scholar
• CasuBGuerriniMGuglieriSUndersulfated and glycol-split heparins endowed with antiangiogenic activityJ Med Chem200447483884814761186
   PubMed Web of Science ®Google Scholar
• SmorenburgSMVan NoordenCJThe complex effects of heparins on cancer progression and metastasis in experimental studiesPharmacol Rev20015319310611171940
   PubMed Web of Science ®Google Scholar
• FargeDDebourdeauPBeckersMInternational clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancerJ Thromb Haemost2013111567023217107
   PubMed Web of Science ®Google Scholar
• MinYAkbulutMKristiansenKThe role of interparticle and external forces in nanoparticle assemblyNat Mater20087752753818574482
   PubMed Web of Science ®Google Scholar
• ChoH-JYoonHYKooHSelf-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic® for tumor-targeted delivery of docetaxelBiomaterials201132297181719021733572
   PubMed Web of Science ®Google Scholar
• ParkKLeeGYParkR-WCombination therapy of heparin–deoxycholic acid conjugate and doxorubicin against squamous cell carcinoma and B16F10 melanomaPharm Res200825226827617619999
   PubMed Web of Science ®Google Scholar
• ParkKLeeGYKimY-SHeparin–deoxycholic acid chemical conjugate as an anticancer drug carrier and its antitumor activityJ Control Release2006114330030616884806
   PubMed Web of Science ®Google Scholar
• LeeJSGoDHBaeJWSynthesis and characterization of heparin conjugated Tetronic®–PCL copolymer for protein drug deliveryCurr Appl Phys20077e49e52
   Google Scholar
• LiSByrneBWelshJSelf-assembled poly(butadiene)-b-poly (ethylene oxide)polymersomes as paclitaxel carriersBiotechnol Prog200723127828517269699
   PubMed Web of Science ®Google Scholar
• Lim SooPEisenbergAPreparation of block copolymer vesicles in solutionJ Polym Sci B Polym Phys2004426923938
   Web of Science ®Google Scholar
• ClarkeSJRivoryLPClinical pharmacokinetics of docetaxelClin Pharmacokinet19993629911410092957
   PubMed Web of Science ®Google Scholar
• MuCFBalakrishnanPCuiFDThe effects of mixed MPEG-PLA/Pluronic copolymer micelles on the bioavailability and multidrug resistance of docetaxelBiomaterials20103182371237920031202
   PubMed Web of Science ®Google Scholar
• HeCHuYYinLEffects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticlesBiomaterials201031133657366620138662
   PubMed Web of Science ®Google Scholar
• ConnerSDSchmidSLRegulated portals of entry into the cellNature20034226927374412621426
   PubMed Web of Science ®Google Scholar
• YouJHuF-QDuY-ZHigh cytotoxicity and resistant-cell reversal of novel paclitaxel loaded micelles by enhancing the molecular-target delivery of the drugNanotechnology2007184949510120442465
   PubMed Web of Science ®Google Scholar
• TermsarasabUChoH-JKimDHChitosan oligosaccharide–arachidic acid-based nanoparticles for anti-cancer drug deliveryInt J Pharm20134411–237338023174411
   PubMedGoogle Scholar
• ParkKKimKKwonICPreparation and characterization of self-assembled nanoparticles of heparin-deoxycholic acid conjugatesLangmuir20042026117261173115595804
   PubMed Web of Science ®Google Scholar
• RosenbergRDHeparin, antithrombin, and abnormal clottingAnnu Rev Med197829136737877142
   PubMedGoogle Scholar
• GaucherGDufresneM-HSantVPBlock copolymer micelles: preparation, characterization and application in drug deliveryJ Control Release2005109116918816289422
   PubMed Web of Science ®Google Scholar
• LeeJSGoDHBaeJWHeparin conjugated polymeric micelle for long-term delivery of basic fibroblast growth factorJ Control Release2007117220420917196698
   PubMed Web of Science ®Google Scholar
• KratohvilJPHsuWPKwokDIHow large are the micelles of di-α-hydroxy bile salts at the critical micellization concentrations in aqueous electrolyte solutions? Results for sodium taurodeoxycholate and sodium deoxycholateLangmuir198622256258
   Web of Science ®Google Scholar
• RizkallaNRangeCLacasseF-XEffect of various formulation parameters on the properties of polymeric nanoparticles prepared by multiple emulsion methodJ Microencapsul2006231395716830976
   PubMed Web of Science ®Google Scholar
• LeeAYLevineMNBakerRILow-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancerN Engl J Med2003349214615312853587
   PubMed Web of Science ®Google Scholar
• NishiokaJGoodinSLow-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survivalJ Oncol Pharm Pract2007132859717873108
   PubMedGoogle Scholar
• JordanMAKamathKHow do microtubule-targeted drugs work? An overviewCurr Cancer Drug Targets20077873074218220533
   PubMed Web of Science ®Google Scholar
• ThorpePEDerbyshireEJAndradeSPHeparin-steroid conjugates: new angiogenesis inhibitors with antitumor activity in miceCancer Res19935313300030077686447
   PubMed Web of Science ®Google Scholar
• LapierreFHolmeKLamLChemical modifications of heparin that diminish its anticoagulant but preserve its heparanase-inhibitory, angiostatic, anti-tumor and anti-metastatic propertiesGlycobiology1996633553668724143
   PubMed Web of Science ®Google Scholar